Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Vertex Pharmaceuticals, Inc. shares valued at $461,198 were sold by Biller Jonathan on Oct 02 ’24. At $461.66 per share, Biller Jonathan sold 999 shares. The insider’s holdings dropped to 16,651 shares worth approximately $7.83 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Biller Jonathan purchased 999 shares, netting a total of over 461,198 in proceeds.
Before that, LEIDEN JEFFREY M had sold 3,784 shares from its account. In a trade valued at $1,888,216, the Executive Chairman traded Vertex Pharmaceuticals, Inc. shares for $499.00 each. Upon closing the transaction, the insider’s holdings decreased to 3,784 shares, worth approximately $4.7 million.
As published in their initiating research note from Scotiabank on October 16, 2024, Vertex Pharmaceuticals, Inc. [VRTX] has been a Sector perform. As of August 05, 2024, Barclays has decreased its “an Overweight” rating to a “an Equal weight” for VRTX. Earlier on June 27, 2024, Redburn Atlantic initiated its rating. Their recommendation was “a Buy” for VRTX stock.
Analyzing VRTX Stock Performance
During the last five days, there has been a drop of approximately -3.53%. Over the course of the year, Vertex Pharmaceuticals, Inc. shares have jumped approximately 15.52%. Shares of the company reached a 52-week high of $510.64 on 08/01/24 and a 52-week low of $391.01 on 04/18/24. A 50-day SMA is recorded $475.11, while a 200-day SMA reached $449.19. Nevertheless, trading volume fell to 0.99 million shares from 1.13 million shares the previous day.
Support And Resistance Levels for Vertex Pharmaceuticals, Inc. (VRTX)
According to the 24-hour chart, there is a support level at 464.06, which, if violated, would cause prices to drop to 458.08. In the upper region, resistance lies at 476.75. The next price resistance is at 483.46. RSI (Relative Strength Index) is 46.93 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.64, which suggests the price will decrease in the coming days. Percent R is at 56.51%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
